RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/29438698http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/29438698http://www.w3.org/2000/01/rdf-schema#comment"Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell (SC)-lineage-derived sarcomas. Molecular events driving SC-to-MPNST transformation are incompletely understood. Here, we show that human MPNSTs exhibit elevated HIPPO-TAZ/YAP expression, and that TAZ/YAP hyperactivity in SCs caused by Lats1/2 loss potently induces high-grade nerve-associated tumors with full penetrance. Lats1/2 deficiency reprograms SCs to a cancerous, progenitor-like phenotype and promotes hyperproliferation. Conversely, disruption of TAZ/YAP activity alleviates tumor burden in Lats1/2-deficient mice and inhibits human MPNST cell proliferation. Moreover, genome-wide profiling reveals that TAZ/YAP-TEAD1 directly activates oncogenic programs, including platelet-derived growth factor receptor (PDGFR) signaling. Co-targeting TAZ/YAP and PDGFR pathways inhibits tumor growth. Thus, our findings establish a previously unrecognized convergence between Lats1/2-TAZ/YAP signaling and MPNST pathogenesis, revealing potential therapeutic targets in these untreatable tumors."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.org/dc/terms/identifier"doi:10.1016/j.ccell.2018.01.005"xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Deng Y."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Wu J."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Xu L."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Wang J."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Zheng Y."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Wang J.'"xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Zhao C."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Zhou W."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Johnson R.L."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Choi K."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Rao R."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Xin M."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Remke M."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Carroll T.J."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Lu Q.R."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Rizvi T.A."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Ratner N."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Stemmer-Rachamimov A.O."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Rubin J.B."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/author"Wu L.M.N."xsd:string
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/29438698http://purl.uniprot.org/core/name"Cancer Cell"xsd:string